Home stool pickups for a gut-inflammation test that GPs order before scopes
TL;DR Gutgauge helps general physicians decide which patients with long-running bowel complaints need a gastroenterologist and a colonoscopy. The GP orders a faecal calprotectin test, Gutgauge collects the sample at home, a partner lab runs it, and the doctor gets a plain next-step note. Patients pay per test. It works if GPs refer fewer people blindly.
Chronic diarrhoea, pain and bloating fill GP clinics. Most cases are functional, but some are inflammatory bowel disease, and the two look alike at first. India's first national IBD registry enrolled 3,863 adults, mostly with ulcerative colitis, at an average age of 36.7[2]. Telling them apart usually takes a colonoscopy, which is unpleasant, costly and scarce outside cities.
There's an Indian twist too. Intestinal tuberculosis mimics Crohn's disease, and one review notes that about a third of Crohn's patients in India receive TB drugs at some point[4]. GPs need a cheap first filter that says whether real inflammation is there at all.
What it does, in regulatory terms - a lab-test service with a triage note for doctors. It screens. It does not diagnose. The test runs in a partner laboratory on an IVD kit licensed under the Medical Devices Rules 2017[5], and only the treating doctor interprets the result.
A GP orders the test from a phone. The patient gets a collection kit and a pickup slot, and the sample reaches the lab cold, inside the stability window. The report comes back with the number and a short note based on published cut-offs. A low result means likely functional, and a high result means refer for endoscopy.
The seed proposed AI analysis of each person's microbiome. I changed it. Personal microbiome reports don't yet lead to a proven clinical action, and the directory already covers diet coaching for bloating. Calprotectin is different - a meta-analysis found that screening with it cut the number of adults needing endoscopy by 67%[1].
The patient pays per test, as with any lab test. I couldn't verify current chain prices, so get quotes from three labs before you price. My assumption is ₹1,800–3,000 including pickup. GPs pay nothing and get faster answers. Gastroenterologists gain better-filtered referrals and may co-sign the triage notes for a small fee per case.
CDSCO brought all IVD kits under its licensing regime by October 2023, so labs and GPs can check what they are using[5]. The DPDP Rules, notified in November 2025, settle what consent a home-collection service needs[6]. Home sample pickup is now normal in Indian cities, which lowers the cost of the first step.
There's no public figure for India's calprotectin testing volume. The narrow signal is clinical - a registry of 3,863 IBD patients from one foundation's network[2], and a test that removes two-thirds of adult endoscopies in screening studies[1]. Treat both as proof of need, not of revenue.
Large Indian lab chains run calprotectin, but they sell it as a line item, not as a GP pathway with pickup and guidance. One European home test kit lets patients run the test at home and read it with a smartphone, though it targets monitoring of people already diagnosed[3]. The gap is a GP-facing service in tier-2 towns that turns one stool sample into a clear referral decision.
| Difficulty | Moderate (34/100) |
| Starting capital | ₹35–70 L |
| Time to launch | 3–6 months |
The science is settled and the lab work is outsourced. Selling is the hard part, because you have to change GP habits one clinic at a time and keep samples cold and on time in towns where couriers are patchy at best.
Yes, though most of the licensing sits with your partners rather than with you.
Building this outside India? The categories above usually have a local equivalent, so check with your own regulator.
Don't let AI read a result as IBD. A high calprotectin also shows up with intestinal TB, so the note stays a screening flag and only the treating doctor interprets it.
Want to work out the AI layer for Gutgauge? Talk to Yash →
Here's what can go south -
I think this is a small, sensible business for a founder from diagnostics sales or lab operations. It is not a venture-scale AI company, and the seed's microbiome promise should stay out of the pitch.
First prove one thing - that GPs in one town order 200 tests in three months and refer fewer patients without findings.
Plan for roughly ₹35–70 L, mostly sales, cold-chain pickup and working capital. The lab work itself is outsourced.
Your partner lab needs state registration and a CDSCO-licensed test kit. You need DPDP compliance for patient data and the usual company and GST registrations.
Yes. The test is used worldwide, so check your own country's lab and medical device rules before you sign a lab partner.
The free Gutgauge validation kit has the line-by-line capital breakdown, the effort scoring, the lab and data-protection checklist, a 14-day validation sprint with pass/fail targets, a 90-day launch plan, 10 interview questions for GPs and patients, and 5 assumptions to test. Download the kit →
Thinking about building Gutgauge or something close to it? The make-or-break work is getting GPs to change how they refer bowel complaints, and that's a sales job I can help you plan. If you need a hand, you know where to find me. Talk to Yash →
For illustration only. Names are fictional and ideas hypothetical; sourced facts are real but may be out of date. Nothing here is legal, financial or professional advice, and Yash Khatri is not personally liable for any use of it. Read the full disclaimer.